Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES
Our common stock is traded on the New York Stock Exchange (NYSE) under the trading symbol BCC. On February 18, 2026, there were 35,722,067 shares of our common stock outstanding, held by five stockholders of record, one of which was Cede & Co., which is the nominee of The Depository Trust Company.
Dividends
Information regarding the payment of dividends is discussed in more detail in Note 12, Stockholders' Equity, of the Notes to Consolidated Financial Statements in "Item 8. Financial Statements and Supplementary Data" of this Form 10-K.
30
Table of Contents
Performance Graph
The following graph compares the return on a $100 investment in our common stock on December 31, 2020, with a $100 investment also made on December 31, 2020, in the S&P SmallCap 600 Index and in our peer group, which is comprised of companies within the S&P 600 Building Products Index. The information in the graph below is not "soliciting material," is not deemed "filed" with the SEC, and is not to be incorporated by reference in any of our filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, except to the extent that we specifically incorporate such information by reference. The stock performance shown below is not necessarily indicative of future performance.
___________________________________
(a) $100 invested in stock or index on December 31, 2020, including reinvestment of dividends in additional shares of the same class of equity securities.
Unregistered Sales of Equity Securities
We did not sell any unregistered securities from January 1, 2025, through December 31, 2025.
31
Table of Contents
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
On October 30, 2025, our board of directors approved a new share repurchase authorization of $300.0 million of our outstanding common stock, excluding applicable fees and taxes. In connection with this authorization, our board of directors terminated the October 30, 2024 authorization to repurchase an additional 1.4 million shares of our outstanding common stock. Share repurchases may be made on an opportunistic basis, through open market transactions, privately negotiated transactions, or by other means in accordance with applicable federal securities laws. We are not obligated to purchase any shares and there is no set date that the share repurchase program will expire. Our board of directors, at its discretion, may increase or decrease the amount authorized or terminate the share repurchase program at any time.
Set forth below is information with respect to the purchases of our common stock during the fourth quarter ended December 31, 2025.
Total Number of Shares Purchased Average Price Paid per Share (exclusive of applicable fees and taxes) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares That May Yet be Purchased Under the Plans or Programs
October 1, 2025 - October 31, 2025 (a) 120,000 $ 75.27 120,000 $ 300,000,000
November 1, 2025 - November 30, 2025 485,743 69.64 485,743 266,173,708
December 1, 2025 - December 31, 2025 366,897 75.03 366,897 238,644,960
Total 972,640 $ 72.37 972,640 $ 238,644,960
___________________________________
(a) Purchases of our common stock in October 2025 were made under the October 30, 2024 board of directors' authorization to repurchase an additional 1.4 million shares of our outstanding common stock. This repurchase program was terminated on October 30, 2025.
ITEM 6. [RESERVED]